| Product NDC: | 68968-3250 |
| Proprietary Name: | STAVZOR |
| Non Proprietary Name: | valproic acid |
| Active Ingredient(s): | 250 mg/1 & nbsp; valproic acid |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68968-3250 |
| Labeler Name: | Noven Therapeutics, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022152 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080801 |
| Package NDC: | 68968-3250-1 |
| Package Description: | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68968-3250-1) |
| NDC Code | 68968-3250-1 |
| Proprietary Name | STAVZOR |
| Package Description | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68968-3250-1) |
| Product NDC | 68968-3250 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | valproic acid |
| Dosage Form Name | CAPSULE, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20080801 |
| Marketing Category Name | NDA |
| Labeler Name | Noven Therapeutics, LLC |
| Substance Name | VALPROIC ACID |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |